Minerva Neurosciences, Inc.
METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SIGMA RECEPTOR MEDIATED DISORDERS

Last updated:

Abstract:

Disclosed herein are compositions and methods for treating a sigma-2 receptor-mediated condition or disorder, including treating one or more symptoms of a sigma-2 receptor-mediated condition or disorder.

Status:
Application
Type:

Utility

Filling date:

29 Jun 2020

Issue date:

15 Apr 2021